GO
Loading...

Cubist Pharma CEO Talks New Lineup

Monday, 29 Apr 2013 | 6:45 PM ET

Cubist Pharmaceuticals is up nearly 9 percent over the last year and has rallied almost 12 percent year-to-date. Michael Bonney, Cubist Pharmaceuticals CEO, weighs in.